News

Researchers are pursuing engineered bacteriophage as alternatives to antibiotics to infect and kill multi-drug resistant bacteria.

An experimental HIV vaccine has reached an important milestone by eliciting antibodies that can neutralize a wide variety of HIV strains.

Although eastern equine encephalitis, a mosquito-borne illness, has existed for centuries, 2019 has been a particularly deadly year for the disease in the US and strategies to address this threat are urgently required.

CRISPR Therapeutics and Vertex Pharmaceuticals have announced their interim safety and efficacy results from the CTX001 CRISPR/Cas9 gene-editing human clinical trials - and they're promising.

Damaged gut lining (leaky gut) in monkeys infected with chronic simian immunodeficiency virus (SIV), an HIV-like virus, was rapidly repaired within five hours of receiving Lactobacillus plantarum bacteria. The outcome lends hope that leaky gut, a common condition among HIV patients, could be effectively treated in the future.

Scientists have taken another big step forward towards developing a vaccine that’s effective against the most severe forms of malaria.

A team from the University of California, Irvine has developed a cell therapy to improve memory and prevent seizures in mice following traumatic brain injury.

Scientists have identified a novel antibody that has the potential to become a new treatment for pulmonary arterial hypertension (PAH). The antibody was found to stop the progress of the disease in rodent and cell models, and reverse the proliferation of cells which cause the arteries to thicken.

A study investigating vaccination-related Facebook ads has revealed that efforts by the platform to improve transparency may have led to the removal of ads promoting vaccination, whilst a small group of unscientific anti-vaccine ad buyers have successfully been able to reach their targeted audiences.

A new study has provided early evidence that an antibody is a safe, effective and rapid food allergy treatment.